Global Forward Capital, originally founded as Trend Forward Capital, is a multi-stage investment firm that bridges cultures, talent, and technology by investing in transformative cybersecurity, enterprise software, and smart connected technologies.
About Trend Forward Capital
Trend Forward Capital, operating at globalforward.com, presents itself as a forward-looking generalist platform but discloses none of the structural details founders need: stage, check size, healthcare verticals, AI focus, or geography are all blank in the input record. The fund name signals a thematic, trend-driven approach rather than a sector specialty, which usually means opportunistic positions across consumer, industrial, and software bets rather than clinically anchored healthcare. Healthcare AI founders should not assume Trend Forward will be a knowledgeable partner on regulatory pathways, payer contracting, or provider GTM, and should plan their pitch around defensible market trends and capital-efficient growth rather than clinical depth. The sweet spot for an investor like this is typically an early-stage software company with a clear narrative arc, where the partner can underwrite category momentum rather than vertical expertise. Anyone running a regulated medical device, drug-discovery platform, or hospital-channel sales motion that depends on long enterprise cycles will likely find better-aligned capital elsewhere. Without a public LinkedIn signal on team and check size, founders should treat the firm as a discovery target requiring a screening conversation before sending a deck. The pragmatic entry path is direct contact through the website plus a LinkedIn message to whoever is listed as managing partner, asking explicitly about active fund deployment, average check size, and whether digital health is on the current mandate. Skip if you need a sector-fluent lead and time-to-term-sheet is critical.
Founder reviews
Other portfolio companies
Companies in Trend Forward Capital's portfolio not currently in our directory.
- Babbly · 2022
- Senior Sign · 2021
- Babbly · 2022
- Lief Therapeutics
Team
Pitch / review this investor
Have you raised from Trend Forward Capital? Founders only — share your honest experience (anonymous OK, moderated before publishing).